Matches in Wikidata for { <http://www.wikidata.org/entity/Q37476656> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- Q37476656 description "article científic" @default.
- Q37476656 description "article scientifique" @default.
- Q37476656 description "articolo scientifico" @default.
- Q37476656 description "artigo científico" @default.
- Q37476656 description "artículu científicu espublizáu en 2008" @default.
- Q37476656 description "bilimsel makale" @default.
- Q37476656 description "scientific article published on October 2008" @default.
- Q37476656 description "vedecký článok" @default.
- Q37476656 description "vetenskaplig artikel" @default.
- Q37476656 description "videnskabelig artikel" @default.
- Q37476656 description "vědecký článek" @default.
- Q37476656 description "wetenschappelijk artikel" @default.
- Q37476656 description "wissenschaftlicher Artikel" @default.
- Q37476656 description "наукова стаття, опублікована в жовтні 2008" @default.
- Q37476656 description "научни чланак" @default.
- Q37476656 description "مقالة علمية نشرت في أكتوبر 2008" @default.
- Q37476656 name "Long-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusion" @default.
- Q37476656 name "Long-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusion" @default.
- Q37476656 name "Long-term safety and efficacy of intravitreal bevacizumab" @default.
- Q37476656 type Item @default.
- Q37476656 label "Long-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusion" @default.
- Q37476656 label "Long-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusion" @default.
- Q37476656 label "Long-term safety and efficacy of intravitreal bevacizumab" @default.
- Q37476656 prefLabel "Long-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusion" @default.
- Q37476656 prefLabel "Long-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusion" @default.
- Q37476656 prefLabel "Long-term safety and efficacy of intravitreal bevacizumab" @default.
- Q37476656 P1104 Q37476656-F5B00234-9CEB-4803-82DC-516BAB369037 @default.
- Q37476656 P1433 Q37476656-D19F3EB4-41EA-4F01-9066-055ECF4655AA @default.
- Q37476656 P1476 Q37476656-79AEFE32-5EA3-4EE2-A9E8-DD9FC964CC51 @default.
- Q37476656 P2093 Q37476656-185BE2F1-9936-41B8-B96E-750FF7E3FC29 @default.
- Q37476656 P2093 Q37476656-5FF702B3-4797-4273-BFB8-462947F8F557 @default.
- Q37476656 P304 Q37476656-D9848A68-47F7-4F6B-86F9-5FF096CF7623 @default.
- Q37476656 P31 Q37476656-D51B0D92-3266-4151-8B76-ED91B067F819 @default.
- Q37476656 P356 Q37476656-03C49FDB-32BD-48EF-BFB6-F01885AF6CE7 @default.
- Q37476656 P433 Q37476656-49A67C6A-B194-4E3C-B6EC-E5AE3B1D26AA @default.
- Q37476656 P478 Q37476656-9861C134-6975-4412-A30C-76221773AFE6 @default.
- Q37476656 P50 Q37476656-26861B32-94A6-4B38-8A9C-189951DAA71E @default.
- Q37476656 P50 Q37476656-2AFB3766-A329-463D-949F-B734A4EF0571 @default.
- Q37476656 P50 Q37476656-3A9D786D-7B72-47C1-B1A0-A26AB61FF1D0 @default.
- Q37476656 P50 Q37476656-4A2EBCEF-15B0-4E9A-845F-F11AC7EDA7C5 @default.
- Q37476656 P50 Q37476656-79A3FFE0-DB9F-4B75-854C-BF931BB6E9FE @default.
- Q37476656 P50 Q37476656-7E04DFD9-01D3-41FC-B857-29061A3B8CFA @default.
- Q37476656 P50 Q37476656-8D39E359-CC97-46CB-BF9B-65B8707CEC6D @default.
- Q37476656 P50 Q37476656-B5788167-FF51-45F8-ACC7-F9E5627F832D @default.
- Q37476656 P50 Q37476656-C269C767-11E5-41FC-BA33-EBA5E84F7715 @default.
- Q37476656 P50 Q37476656-DBCE5A24-0AD8-4FF0-B948-71BE9F8CA551 @default.
- Q37476656 P50 Q37476656-DDD8AC50-024D-4426-9AB8-209ACECED090 @default.
- Q37476656 P577 Q37476656-B586A113-7F61-4C58-903A-4C2BF5CAA4F5 @default.
- Q37476656 P698 Q37476656-01E23AA6-F25C-4854-8AB9-5D05EAABA4C5 @default.
- Q37476656 P8608 Q37476656-F2D4B1B7-A0B2-47F3-BD44-C8D462891D0F @default.
- Q37476656 P921 Q37476656-15048381-BE73-436B-B287-F25D893A3DB2 @default.
- Q37476656 P356 IAE.0B013E318188501F @default.
- Q37476656 P698 19430392 @default.
- Q37476656 P1104 "+13" @default.
- Q37476656 P1433 Q15753094 @default.
- Q37476656 P1476 "Long-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusion" @default.
- Q37476656 P2093 "Jaime Gaitan" @default.
- Q37476656 P2093 "Timothy G Murray" @default.
- Q37476656 P304 "1325-1337" @default.
- Q37476656 P31 Q13442814 @default.
- Q37476656 P356 "10.1097/IAE.0B013E318188501F" @default.
- Q37476656 P433 "9" @default.
- Q37476656 P478 "28" @default.
- Q37476656 P50 Q114427402 @default.
- Q37476656 P50 Q114427406 @default.
- Q37476656 P50 Q114427407 @default.
- Q37476656 P50 Q114427412 @default.
- Q37476656 P50 Q114427417 @default.
- Q37476656 P50 Q5043412 @default.
- Q37476656 P50 Q56850795 @default.
- Q37476656 P50 Q66389057 @default.
- Q37476656 P50 Q85841924 @default.
- Q37476656 P50 Q89902165 @default.
- Q37476656 P50 Q91705265 @default.
- Q37476656 P577 "2008-10-01T00:00:00Z" @default.
- Q37476656 P698 "19430392" @default.
- Q37476656 P8608 "release_5zowtfsvrjauffg3mxmhx6sngq" @default.
- Q37476656 P921 Q413299 @default.